- Home
- BG vs EXAS Comparison
BG vs EXAS Comparison
Compare BG & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BG
- EXAS
- Stock Information
- Founded
- BG 1818
- EXAS 1995
- Country
- BG United States
- EXAS United States
- Employees
- BG N/A
- EXAS N/A
- Industry
- BG Packaged Foods
- EXAS Medical Specialities
- Sector
- BG Consumer Staples
- EXAS Health Care
- Exchange
- BG Nasdaq
- EXAS Nasdaq
- Market Cap
- BG 10.1B
- EXAS 8.8B
- IPO Year
- BG N/A
- EXAS N/A
- Fundamental
- Price
- BG $77.99
- EXAS $44.56
- Analyst Decision
- BG Buy
- EXAS Strong Buy
- Analyst Count
- BG 4
- EXAS 18
- Target Price
- BG $90.00
- EXAS $70.59
- AVG Volume (30 Days)
- BG 1.9M
- EXAS 1.9M
- Earning Date
- BG 04-23-2025
- EXAS 05-01-2025
- Dividend Yield
- BG 3.49%
- EXAS N/A
- EPS Growth
- BG N/A
- EXAS N/A
- EPS
- BG 7.99
- EXAS N/A
- Revenue
- BG $53,108,000,000.00
- EXAS $2,758,867,000.00
- Revenue This Year
- BG $7.65
- EXAS $12.98
- Revenue Next Year
- BG $1.82
- EXAS $12.96
- P/E Ratio
- BG $9.76
- EXAS N/A
- Revenue Growth
- BG N/A
- EXAS 10.37
- 52 Week Low
- BG $67.40
- EXAS $40.62
- 52 Week High
- BG $114.92
- EXAS $74.44
- Technical
- Relative Strength Index (RSI)
- BG 64.81
- EXAS 43.16
- Support Level
- BG $74.90
- EXAS $42.51
- Resistance Level
- BG $75.50
- EXAS $47.23
- Average True Range (ATR)
- BG 1.80
- EXAS 1.56
- MACD
- BG 0.47
- EXAS 0.12
- Stochastic Oscillator
- BG 98.89
- EXAS 43.43
About BG Bunge Limited
Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes and corn-based products in North and South America.
About EXAS Exact Sciences Corporation
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.